58 related articles for article (PubMed ID: 36180402)
21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
22. Pharmacotherapy weight-loss interventions to prevent type 2 diabetes in overweight or obese adults and older adults: A protocol for systematic review and network meta-analysis.
Yang W; Wen J; Wu F; Zeng H; Guo B; Ge L
Medicine (Baltimore); 2021 Mar; 100(11):e24812. PubMed ID: 33725948
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial.
Garvey WT; Birkenfeld AL; Dicker D; Mingrone G; Pedersen SD; Satylganova A; Skovgaard D; Sugimoto D; Jensen C; Mosenzon O
Diabetes Care; 2020 May; 43(5):1085-1093. PubMed ID: 32139381
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials.
Lin Q; Xue Y; Zou H; Ruan Z; Ung COL; Hu H
Expert Rev Clin Pharmacol; 2022 Dec; 15(12):1461-1469. PubMed ID: 36180402
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Liraglutide 3.0 mg in Patients with Overweight and Obese with or without Diabetes: A Systematic Review and Meta-Analysis.
Konwar M; Bose D; Jaiswal SK; Maurya MK; Ravi R
Int J Clin Pract; 2022; 2022():1201977. PubMed ID: 35936066
[TBL] [Abstract][Full Text] [Related]
26. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Vilsbøll T; Christensen M; Junker AE; Knop FK; Gluud LL
BMJ; 2012 Jan; 344():d7771. PubMed ID: 22236411
[TBL] [Abstract][Full Text] [Related]
27. Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis.
Sun F; Chai S; Li L; Yu K; Yang Z; Wu S; Zhang Y; Ji L; Zhan S
J Diabetes Res; 2015; 2015():157201. PubMed ID: 25688373
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review.
Xie Z; Yang S; Deng W; Li J; Chen J
Clin Epidemiol; 2022; 14():1463-1476. PubMed ID: 36510488
[TBL] [Abstract][Full Text] [Related]
29. Green tea for weight loss and weight maintenance in overweight or obese adults.
Jurgens TM; Whelan AM; Killian L; Doucette S; Kirk S; Foy E
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD008650. PubMed ID: 23235664
[TBL] [Abstract][Full Text] [Related]
30. Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
LeBlanc ES; Patnode CD; Webber EM; Redmond N; Rushkin M; O'Connor EA
JAMA; 2018 Sep; 320(11):1172-1191. PubMed ID: 30326501
[TBL] [Abstract][Full Text] [Related]
31. Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.
Zhang F; Tong Y; Su N; Li Y; Tang L; Huang L; Tong N
J Diabetes; 2015 May; 7(3):329-39. PubMed ID: 25043423
[TBL] [Abstract][Full Text] [Related]
32. Exenatide in obese or overweight patients without diabetes: A systematic review and meta-analyses of randomized controlled trials.
Su N; Li Y; Xu T; Li L; Kwong JS; Du H; Ren K; Li Q; Li J; Sun X; Li S; Tian H
Int J Cardiol; 2016 Sep; 219():293-300. PubMed ID: 27343423
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T
Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: A network meta-analysis of randomized clinical trials.
Alkhezi OS; Alahmed AA; Alfayez OM; Alzuman OA; Almutairi AR; Almohammed OA
Obes Rev; 2023 Mar; 24(3):e13543. PubMed ID: 36579723
[TBL] [Abstract][Full Text] [Related]
35. Weight loss interventions for chronic asthma.
Adeniyi FB; Young T
Cochrane Database Syst Rev; 2012 Jul; (7):CD009339. PubMed ID: 22786526
[TBL] [Abstract][Full Text] [Related]
36. Liraglutide: a review of its use in the management of obesity.
Scott LJ
Drugs; 2015 May; 75(8):899-910. PubMed ID: 25985864
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
